Brief: Breckenridge Announces Tentative Approval Of Its ANDA For Dabigatran Etexilate Capsules (Generic For Pradaxa®)
22/04/2022 18:25
April 22 (Reuters) -
* BRECKENRIDGE ANNOUNCES TENTATIVE APPROVAL OF ITS ANDA FOR
DABIGATRAN ETEXILATE CAPSULES (GENERIC FOR PRADAXA®)
Source text for Eikon: urn:newsml:reuters.com:*:nPncxKbVa
Further company coverage: 4553.T
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on TOWA PHARMACEUTICAL
See all newsTable: Towa Pharmaceutical -Q1 group results
Notice Of Acquisition Of Shares Of Tanabe Pharma Factory And Transfer Of Manufacturing And Marketing Approvals
Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
Table: Towa Pharmaceutical -2025/26 parent results
Table: Towa Pharmaceutical -2025/26 group results